Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 352

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy

Querol, Luis, Nogales‐Gadea, Gisela, Rojas‐Garcia, Ricard, Martinez‐Hernandez, Eugenia, Diaz‐Manera, Jordi, Suárez‐Calvet, Xavier, Navas, Miquel, Araque, Josefa, Gallardo, Eduard, Isabel Illa·2013·Annals of Neurology

Abstract

Objective: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a frequent autoimmune neuropathy with a heterogeneous clinical spectrum. Clinical and experimental evidence suggests that autoantibodies may be involved in its pathogenesis, but the target antigens are unknown. Axoglial junction proteins have been proposed as candidate antigens. We examined the reactivity of CIDP patients' sera against neuronal antigens and used immunoprecipitation for antigen unraveling. Methods: Primary cultures of hippocampal neurons were used to select patients' sera that showed robust reactivity with the cell surface of neurons. The identity of the antigens was established by immunoprecipitation and mass spectrometry, and subsequently confirmed with cell‐based assays, immunohistochemistry with teased rat sciatic nerve, and immunoabsorption experiments. Results: Four of 46 sera from patients with CIDP reacted strongly against hippocampal neurons (8.6%) and paranodal structures on peripheral nerve. Two patients' sera precipitated contactin‐1 (CNTN1), and 1 precipitated both CNTN1 and contactin‐associated protein 1 (CASPR1). Reactivity against CNTN1 was confirmed in 2 cases, whereas the third reacted only when CNTN1 and CASPR1 were cotransfected. No other CIDP patient or any of the 104 controls with other neurological diseases tested positive. All 3 patients shared common clinical features, including advanced age, predominantly motor involvement, aggressive symptom onset, early axonal involvement, and poor response to intravenous immunoglobulin. Interpretation: Antibodies against the CNTN1/CASPR1 complex occur in a subset of patients with CIDP who share common clinical features. The finding of this biomarker may help to explain the symptoms of these patients and the heterogeneous response to therapy in CIDP. ANN NEUROL 2013;73:370–380

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.23794

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 352

Metadata

Authors
Querol, L., Nogales‐Gadea, G., Rojas‐Garcia, R., Martinez‐Hernandez, E., Diaz‐Manera, J., Suárez‐Calvet, X., Navas, M., Araque, J., Gallardo, E., & Illa, I.
Venue
Annals of Neurology
Publisher
Wiley
Published
2012-12-31
Volume
73
Issue
3
Pages
370-380
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1566573763
Cited by
352
References
27
FWCI
9.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy. https://app.cochat.ai/papers/10.1002/ana.23794
The paper
Querol, L., Nogales‐Gadea, G., Rojas‐Garcia, R., Martinez‐Hernandez, E., Diaz‐Manera, J., Suárez‐Calvet, X., Navas, M., Araque, J., Gallardo, E., & Illa, I. (2013). Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy. Annals of Neurology. https://doi.org/10.1002/ana.23794

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.